Table 1.
Clinical summary and pathology features of UTROSCT (cases 1-4) and ESTSCLE (cases 5-6)
| Case | Age | Presentation | Surgery | Gross | Cervical involvement | Extra-uterine spread | Lymphovascular invasion | Adjuvant treatment | Patient outcome |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 49 | Asymptomatic | TAH | 6.3 cm, Intramural, solid mass | No | No | No | None | NED 7 years |
| 2 | 50 | Abnormal menstruation | Transvaginal submucous myomectomy | 4.5 cm, Uterine isthmus mass protruding through cervical os | Yes | No | No | None | Recurrent 10 months, TAH, NED 5 years |
| 3 | 47 | Abnormal menstruation | TCRM, subsequent TAH | 3 cm, Polypoid submucous | No | No | No | None | NED 6 months |
| 4 | 35 | Abnormal menstruation | Myomectomy, subsequent TAH | 10.2 cm, Intramural, solid-cystic mass, Infiltrative margins | No | No | No | None | NED 3 months |
| 5 | 44 | Abnormal menstruation | TVH | 5.8 cm, Polypoid submucous mass | No | No | No | Chemotherapy | Recurrent 4 years |
| 6 | 46 | Incidental | TAH+BSO | 4 cm, Intramural solid mass | No | No | No | Not known | Lost to follow-up |
TAH: total abdominal hysterectomy; TCRM: transcervical resection myoma; TVH: total vaginal hysterectomy; BSO: bilateral salpingo-oophorectomy; NED: no evidence of disease.